Litchman Manuel MD
- SEC CIK
- 0001709485
No open-market purchases or sales filed in the past year.
Current role at each company
- MBIO Mustang Bio, Inc.President, CEO and Interim CFOas of Apr 27, 2026
Open-market trades in the past year
Open-market purchases (P) and sales (S) filed in the last 365 days, not counting derivative securities or duplicate filings. Values leave out price outliers.
- Bought
- –
- 0 filings
- Sold
- –
- 0 filings
- Net
- –
- Bought minus sold
- Companies
- 0
- With open-market trades
Trades
Every Form 4 that lists Litchman Manuel MD as a reporting owner, including filings made jointly with others, grouped by company. Each row adds up one type of transaction in one filing. Only open-market purchases (P) and sales (S) are shown by default.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Apr 3, 2023 (view filing) | Mar 18-Sep 13, 2022 | 381 daysLate | Litchman Manuel MDDirector | PPurchaseCOMMON STOCK, PAR VALUE $0.0001 | +10.0K | $0.63 | +$6.30K | +0.9%1.10M after | 2 lots |
| Nov 8, 2021 (view filing) | Oct 27 | 12 daysLate | Litchman Manuel MDPresident and CEO | PPurchase | +65.0K | $2.24 | +$145.6K | +6.7%1.03M after | |
| Aug 5, 2021 (view filing) | Jul 30 | 6 daysLate | Litchman Manuel MDPresident and CEO | PPurchase | +86.2K | $2.91 | +$250.9K | +9.9%960.2K after |